Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 179

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Intolerance to Statins: Mechanisms and Management

Open access
Bitzur, Rafael, Cohen, Hofit, Kamari, Yehuda, Harats, Dror · 2013 · Diabetes Care

Abstract

S tatins are considered very effectivein reducing cardiovascular morbid-ity and mortality in high-risk pa-tients. However, although adherence to statins improves morbidity and mortality (1), it remains suboptimal (2). One of the most important causes of nonadherence is the so-called statin intolerance, mainly because of muscle-related symptoms. These symptoms most often consist of myalgia unaccompanied by significant creatine kinase (CK) elevations. Less of-ten, myositis (elevated CK.10 times the upper limit of normal) or rhabdomyolysis (CK level.10,000 IU/L or accompanied by significant elevation in creatinine level) develops. In randomized controlled trials, the incidence of statin myopathy is ~1.5– 5.0 % (3). However, this low incidence may be misleading for several reasons. First, in most studies patients with a his-tory of statin intolerance were excluded. Other studies had a single-blinded statin run-in phase, and patients experiencing muscle-related symptoms or CK eleva-tions during this phase were excluded. Patients who tend to be at risk for devel-oping muscle-related symptoms, such as women, elderly patients, and patients with significant comorbidity, who com-prise a large proportion of statin-treated patients in real-life settings, are underrep-resented in randomized controlled trials. Some studies have definedmuscle-related effects by elevated CK levels only, disre-garding myalgia. Last but not least, pa-tients enrolled in studies might be motivated and so minimize reporting of mild myalgias, thus leading to underesti-mation of the magnitude of the problem. Data concerning real-life incidence of statin-related myopathy are scarce. In the

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dcs13-2038

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 179

Metadata

Authors
Bitzur, R., Cohen, H., Kamari, Y., & Harats, D.
Venue
Diabetes Care
Published
2013-07-17
Volume
36
Issue
Supplement_2
Pages
S325-S330
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2107969192
Cited by
179
References
19
FWCI
12.87
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intolerance to Statins: Mechanisms and Management. https://app.cochat.ai/papers/10.2337/dcs13-2038
The paper
Bitzur, R., Cohen, H., Kamari, Y., & Harats, D. (2013). Intolerance to Statins: Mechanisms and Management. Diabetes Care. https://doi.org/10.2337/dcs13-2038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.